Clinical Trial on NASH & Fibrosis

Clinical Trial on NASH & Fibrosis
03/21/2025 05/19/2025 medium

A local research facility is seeking participants aged 18-80 for a clinical research study on NASH and Fibrosis. This study is testing an investigational injectable medication for the treatment of Non-Alcoholic Steatohepatitis (NASH), newly known as Metabolic Dysfunction Associated Steatohepatitis (MASH) and Fibrosis.

Total participation will last approximately 3 years and 4 months, including 14 doctor’s visits and 4 phone visits throughout the study.

Trial-related procedures and study medication will be provided at no cost.


Space is limited, subject to availability. Criteria for qualification are subject to change at any time and without notice.

Click here to Register

Featured Studies

Other Studies